4//SEC Filing
Rottinghaus Scott T. 4
Accession 0002064832-25-000028
CIK 0001177648other
Filed
Nov 25, 7:00 PM ET
Accepted
Nov 26, 5:05 PM ET
Size
5.5 KB
Accession
0002064832-25-000028
Insider Transaction Report
Form 4
Rottinghaus Scott T.
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2025-11-25+110,000→ 110,000 totalExercise: $13.66Exp: 2035-11-25→ Common Stock (110,000 underlying)
Footnotes (1)
- [F1]Such option will become exercisable (subject to the optionholder's continued employment) quarterly in substantially equal installments (any fractional shares to be cumulated and to become exercisable at the end of the earliest succeeding quarterly period in which a whole share equivalent is accumulated) over four years from the date of grant (November 25, 2025).
Issuer
ENANTA PHARMACEUTICALS INC
CIK 0001177648
Entity typeother
Related Parties
1- filerCIK 0001942407
Filing Metadata
- Form type
- 4
- Filed
- Nov 25, 7:00 PM ET
- Accepted
- Nov 26, 5:05 PM ET
- Size
- 5.5 KB